Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Serina Therapeutics (SER) Shares Outstanding (2017 - 2025)

Serina Therapeutics' Shares Outstanding history spans 9 years, with the latest figure at $965000.0 for Q3 2025.

  • For Q3 2025, Shares Outstanding fell 89.15% year-over-year to $965000.0; the TTM value through Sep 2025 reached $965000.0, down 89.15%, while the annual FY2024 figure was $9.4 million, 290.95% up from the prior year.
  • Shares Outstanding for Q3 2025 was $965000.0 at Serina Therapeutics, down from $10.1 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $37.9 million in Q3 2022 and bottomed at $1079.0 in Q4 2021.
  • The 5-year median for Shares Outstanding is $2.4 million (2023), against an average of $11.7 million.
  • The largest annual shift saw Shares Outstanding tumbled 97.14% in 2021 before it surged 200734.11% in 2022.
  • A 5-year view of Shares Outstanding shows it stood at $1079.0 in 2021, then soared by 200734.11% to $2.2 million in 2022, then rose by 11.21% to $2.4 million in 2023, then skyrocketed by 290.95% to $9.4 million in 2024, then tumbled by 89.76% to $965000.0 in 2025.
  • Per Business Quant, the three most recent readings for SER's Shares Outstanding are $965000.0 (Q3 2025), $10.1 million (Q2 2025), and $9.9 million (Q1 2025).